Fingerprint
Dive into the research topics of 'Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
the KEYNOTE-522 Investigators
Research output: Contribution to journal › Article › peer-review
427
Scopus
citations